MIRA Pharmaceuticals, Inc. (MIRA) Net income 2022–2025
MIRA Pharmaceuticals, Inc. (MIRA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$10.4MFY2025 · since FY2022: -$7.1M → -$10.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.4M | -33.0% |
| FY2024 | -$7.9M | +34.5% |
| FY2023 | -$12.0M | -69.8% |
| FY2022 | -$7.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MIRA financial trends
MIRA RevenueMIRA Net marginMIRA Gross profitMIRA Gross marginMIRA Operating incomeMIRA Operating marginMIRA Operating cash flowMIRA Free cash flowMIRA Capital expendituresMIRA Return on equityMIRA Stock buybacksMIRA Dividends paidMIRA Total assetsMIRA Total liabilitiesMIRA Shareholders’ equityMIRA overview →